Immune modulation by TCDD and related polyhalogenated aromatic hydrocarbons

Immunotoxicology and Immunopharmacology, Third Edition

Volumn , Issue , 2006, Pages 239-258

  Paige Lawrence, B ^a   Kerkvliet, Nancy I ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920991069     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (131)

1. Kerkvliet, N.I., T lymphocyte subpopulations and TCDD immunotoxicity, in T Lymphocyte Subpopulations in Immunotoxicology, Kimber, I. and Selgrade, M., eds. John Wiley & Sons, Chichester, England, 1998, p. 55.
2. Kerkvliet, N.I., Recent advances in understanding the mechanisms of TCDD immunotoxicity, Int. Immunopharmacol., 2, 277, 2002.
3. Kerkvliet, N.I., Immunotoxicology of dioxins and related chemicals, in Dixoins and Health, 2nd ed., Schecter, A. and Gasiewicz, T., eds. A. John Wiley & Sons, Hoboken, NJ, 2003.
4. Kerkvliet, N.I. and Burleson, G., Immunotoxicity of TCDD and related halogenated aromatic hydrocarbons, in Immunotoxicology and Immunopharmacology, 2 ed., J.H. Dean, A.E. Munson, and I. Kimber, eds. Raven Press, New York, 1994, p. 97.
5. Staples, J., et al., Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells, J. Immunol., 160, 3844, 1998.
6. Vorderstrasse, B.A., et al., Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression, Toxicol. Appl. Pharmacol., 171, 157, 2001.
7. Fernandez-Salguero, P., et al., Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor, Science, 268, 722, 1995.
8. Hayashi, S., et al., Expression of Ah receptor (TCDD receptor) during human monocytic differentiation, Carcinogenesis. 16, 1403, 1995.
9. Lawrence, B.P., Leid, M., and Kerkvliet, N.I., Distribution and behavior of the Ah receptor from murine T lymphocytes, Toxicol. Appl. Pharmacol., 138, 275, 1996.
10. Matsen, S. and Shiverick, K., Characterization of the aryl hydrocarbon receptor complex in human B lymphocytes: Evidence for a distinct nuclear DNA-binding form, Arch. Biochem. Biophys., 36, 1996
11. Yamaguchi, K., et al., Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent pre-B cell apoptosis, J. Immunol., 158, 2165, 1997.
12. Marcus, R., Holsapple, M., and Kaminski, N., Lipopolysaccharide activation of murine splenocytes and splenic B cells increased the expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator, J. Pharmacol. Exper. Therap. 287, 1113, 1998.
13. Uno, S., et al., Cyp1a1(-/-) male mice: Protection against high dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and urophorhyria, Toxicol. Appl. Pharmacol., 196, 410, 2004.
14. Lai, Z., Pineau, T., and Esser, C., Identification of dioxin-responsive elements (DREs) in the 5' regions of putative dioxin-inducible genes, Chemico-Biological Interact., 100, 97, 1996.
15. Zeytun, A., et al., Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays, Toxicology, 178, 241, 2002.
16. Tian, Y., et al., Ah receptor and NF-kappa B interactions, a potential mechanism for dioxin toxicity, J. Biol. Chem., 274, 510, 1999.
17. Kim, D., et al., The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells, Oncogene, 19, 5498, 2000.
18. Puga, A., et al., Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest, J. Biol. Chem., 275, 2943, 2000.
19. Ruby, C., Leid, M., and Kerkvliet, N.I., 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-α and anti-CD40-induced activation of NF-κB/Rel in dendritic cells: p50 homodimer activation is not affected, Molec. Pharmacol., 62, 722, 2002.
20. Carver, L. and Bradfield, C., Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo, J. Biol. Chem., 272, 11452, 1997.
21. Ma, Q. and Whitlock, J. P., A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin, J. Biol. Chem., 272, 8878, 1997.
22. Meyer, B., et al., Hepatitis B virus X-associate protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity, Mol. Cell. Biol., 18, 978, 1998.
23. Pohjanvirta, R. and Tuomisto, J., Short-term toxicity of TCDD in laboratory animals: Effects, mechanisms and animal models, Pharmacol. Rev., 46, 483, 1994.
24. Fernandez-Salguero, P., et al., Aryl hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity, Toxicol. Appl. Pharmacol., 140, 173, 1996.
25. Kremer, J., Gleichmann, E., and Esser, C., Thymic stroma exposed to aryl hydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation, J. Immunol., 153, 2778, 1994.
26. Laiosa, M., et al., Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor, J. Immunol., 171, 4582, 2003.
27. Fine, J., et al., Prothymocyte activity is reduced by perinatal 2,3,7,8-tetrachlorodibenzop- dioxin exposure, J. Pharmacol. Exp. Therap., 255, 128, 1990.
28. Tsukumo, S., et al., Skewed differentiation of thymocytes toward CD8 T cells by 2,3,7,8- tetrachlorodibenzo-p-dioxin requires activation of the extracellular signal-related kinase pathway, Arch. Toxicol., 76, 335, 2002.
29. Fisher, M., Nagarkatti, M., and Nagarkatti, P., Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity, Toxicol. Sci., 78, 96, 2003.
30. Fisher, M., Nagarkatti, M., and Nagarkatti, P., 2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery, Mol. Pharmacol., 67, 327, 2004.
31. Staples, J., et al., Overexpression of the anti-apoptotic oncogene bcl-2 in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicol. Appl. Pharmacol., 151, 200, 1998.
32. Lai, Z., et al., Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-pdioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture, Toxicol. Appl. Pharmacol., 168, 15, 2000.
33. Rhile, M. J., Nagarkatti, M., and Nagarkatti, P. S., Role of Fas apoptosis and MHC genes in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunotoxicity of T cells, Toxicology, 110, 153, 1996.
34. Kamath, A., et al., Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD)-induced immunotoxicity: Increased resistance of thymocytes from Fasdeficient (lpr) and Fas ligand-deficient (gld) mice to TCDD-induced toxicity, Toxicol. Appl. Pharmacol., 160, 141, 1999.
35. Kamath, A., et al., Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo- p-dioxin in vivo, Toxicol. Appl. Pharmacol., 142, 367. 1997.
36. Svensson, C., et al., Dioxin-induced adseverin expression in the mouse thymus is strictly regulated and dependent on the aryl hydrocarbon receptor, Biochem. Biophys. Res. Comm., 291, 1194, 2002.
37. Tomita, S., et al., T cell-specific disruption of the aryl hydrocarbon receptor nuclear transporter (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution, J. Immunol., 171, 4113, 2003.
38. Greenlee, W., et al., Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium, Tox. Appl. Pharmacol., 79, 112, 1985.
39. Camacho, I., et al., Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappa B and expression of Fas ligand in thymic stromal cells and consequent T cell apoptosis, J. Immunol., 175, 90, 2005.
40. Riecke, K., Schmidt, A., and Stahlmann, R., Effects of 2,3,7,8-TCDD and PCB 126 on human thymic epithelial cells in vitro, Arch. Toxicol., 77, 358, 2003.
41. Svensson, C. and Lundberg, K., Immune-specific up-regulation of adseverin gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Molec. Pharmacol., 60, 135, 2001.
42. Fine, J., Silverstone, A., and Gasiewicz, T. A., Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin, J. Immunol., 144, 1169, 1990.
43. Frazier, D., et al., The thymus does not mediate 2,3,7,8-tetrachlorodibenzo-p-dioxin-elicited alterations in bone marrow lymphocyte stem cells, Toxicol. Appl. Pharmacol., 124, 242, 1994.
44. Murante, F. and Gasiewicz, T., Hemopoietic progenitor cells are sensitive targets of 2,3,7,8- tetrachlorodibenzo-p-dioxin in C57Bl/6j mice, Toxicol. Sci., 54, 374, 2000.
45. Thurmond, T.S. and Gasiewicz, T.A., A single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin produces a time and dose-dependent alteration in the murine bone marrow B-lymphocyte maturation profile, Toxicol. Sci., 58, 88, 2000.
46. Thurmond, T.S., et al., The aryl hydrocarbon receptor has a role in the in vivo maturation of murine bone marrow B lymphocytes and their response to 2,3,7,8-tetrachlorodibenzop- dioxin, Toxicol. Appl. Pharmacol., 165, 227, 2000.
47. Silverstone, A., Frazier, D., Jr. and Gasiewicz, T.A., Alternate immune system targets for TCDD: Lymphocyte stem cells and extrathymic T cell development, Exp. Clin. Immunogenet., 11, 94, 1994.
48. Lavin, A., Hahn, D., and Gasiewicz, T.A., Expression of functional aromatic hydrocarbon receptor and aromatic hydrocarbon nuclear translocator proteins in murine bone marrow stromal cells, Arch. Biochem. Biophys., 352, 9, 1998.
49. Near, R., et al., Regulation of preB cell apoptosis by aryl hydrocarbon/transcription factor- expressing stromal/adherent cells, Proc. Soc. Exp. Biol. Med., 221, 242, 1999.
50. Sakai, R., et al., TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells, Toxicol. Sci., 72, 84, 2003.
51. Wyman, A., et al., 2,3,7,8-Tetrachlorodibenzo-p-dioxin does not directly alter the phenotype of maturing B cells in a murine coculture system, Toxicol. Appl. Pharmacol., 180, 164, 2002.
52. Sulentic, C., Holsapple, M., and Kaminski, N., Aryl hydrocarbon receptor-dependent suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin of IgM secretion by activated B cells, Mol. Pharmacol., 53, 623, 1998.
53. Sulentic, C., Holsapple, M., and Kaminski, N., Putative link between transcriptional regulation of IgM expression by TCDD and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway, J. Pharmacol. Exper. Therapeut., 295, 705, 2000.
54. Sulentic, C., et al., Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3‘alpha immunoglobulin heavy chain enhancer, Toxicology, 200, 235, 2004.
55. Matsen, S. and Shiverick, K., The Ah receptor recognizes DNA binding sites for the B cell transcription factor BSAP: A possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes, Biochem. Biophys. Res. Comm., 212, 27, 1995.
56. Nagai, H., et al., Search for the target genes involved in the suppression of antibody production by TCDD in C57Bl/6 mice, Int. Immunopharmacol., 5, 331, 2005.
57. Boverhof, D., et al., 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells, Mol. Pharmacol., 66, 1662, 2004.
58. Yoo, B., et al., 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells, Toxicol. Sci., 77, 272, 2004.
59. Crawford, R., et al., 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells, Toxicol. Sci., 75, 333, 2003.
60. Suh, J., et al., Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8- tetrachlorodibenzo-p-dioxin in activated B cells, Toxicol. Appl. Pharmacol., 181, 116, 2002.
61. Inouye, K., et al., Suppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the high-affinty antibody response in C57Bl/6 mice, Toxicol. Sci., 74, 315, 2003.
62. Ito, T., et al., Mechanism of TCDD-induced suppression of antibody production: Effect on T cell-derived cytokine production in the primary immune reaction of mice, Toxicol. Sci., 70, 46, 2002.
63. Fujimaki, H., et al., Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/NgA mice, Toxicol. Sci., 66, 117, 2002.
64. Mitchell, K. and Lawrence, B.P., T cell receptor transgenic mice provide novel insights into understanding cellular targets of TCDD: Suppression of antibody production, but not the response of CD8+ T cells, during infection with influenza virus, Toxicol. Appl. Pharmacol., 192, 275, 2003.
65. Andersson, P., et al., A constitutively active aryl hydrocarbon receptor causes loss of peritoneal B1 cells, Biochem. Biophys. Res. Comm., 302 236, 2003.
66. Kerkvliet, N. I., Shepherd, D. M., and Baecher-Steppan, L., T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD, Toxicol. Appl. Pharmacol., 185, 146, 2002.
67. Doi, H., et al., Functional activation of aryl hydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Chemosphere, 52, 655, 2003.
68. Lundberg, K., Dencker, L., and Gronvik, K., 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits the activation of antigen specific T cells in mice, Int. J. Immunopharmacol., 14, 699, 1992.
69. Prell, R., Oughton, J., and Kerkvliet, N.I., Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T cell subsets and cytokine production, Int. J. Immunopharmacol., 17, 951, 1995.
70. Lawrence, B.P. and Kerkvliet, N.I., T helper clones and in vitro assessment of immunotoxicity, in T Lymphocyte Subpopulations in Immunotoxicology, Kimber, I. and Selgrade, M.J., eds. John Wiley & Sons, New York, 1998, p. 143.
71. Pryputniewicz, S., Nagarkatti, M., and Nagarkatti, P., Differential induction of apoptosis in activated and resting T cells by TCDD and its repercussion on T cell responsiveness, Toxicology, 129, 211, 1998.
72. Shepherd, D. M., Dearstyne, E. A., and Kerkvliet, N. I., The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4(+) T cells in adoptively transferred mice, Toxicol. Sci., 56, 340, 2000.
73. Funatake, C., et al., Early consequences of 2,3,7,8-tetrachlorodibenzo-p-dioixn exposure on the activation and survival of antigen-specific T cells, Toxicol. Sci., 82, 129, 2004.
74. Camacho, I., Nagarkatti, M., and Nagarkatti, P., 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen primed T cells, Arch. Toxicol., 76, 570, 2002.
75. Funatake, C., et al., Cutting Edge: Activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) generates a population of CD4+CD25+ cells with characteristics of regulatory T cells, J. Immunol., 175, 4184, 2005.
76. Belkaid, Y. and Rouse, B., Natural regulatory T cells in infectious disease, Nat. Immunol., 6, 353, 2005.
77. Kerkvliet, N.I., et al., Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin, J. Immunol., 157, 2310, 1996.
78. Prell, R., et al., CTL hyporesponsiveness induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Role of cytokines and apoptosis, Toxicol. Appl. Pharmacol., 166, 214, 2000.
79. Mitchell, K. and Lawrence, B.P., Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin renders influenza virus-specific CD8+ T cells hyporesponsive to antigen, Toxicol. Sci., 74, 74, 2003.
80. Neff-LaFord, H., Vorderstrasse, B., and Lawrence, B.P., Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice, Cell. Immunol., 226, 54, 2003.
81. Vorderstrasse, B., Bohn, A., and Lawrence, B.P., Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD, Toxicology, 188, 15, 2003.
82. Warren, T., Mitchell, K., and Lawrence, B.P., Exposure to 2,3,7,8-tetrachlorodibenzo-p dioxin suppresses the cell-mediated and humoral immune response to influenza A virus without affecting cytolytic activity in the lung., Toxicol. Sci., 56, 114, 2000.
83. Prell, R. and Kerkvliet, N.I., Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the alloantibody response to P815 mastocytoma, J. Immunol., 158, 2695, 1997.
84. Shepherd, D., et al., Anti-CD40 Treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDDinduced suppression of allograft immunity, Toxicol. Appl. Pharmacol., 170, 10, 2001.
85. Vorderstrasse, B. and Kerkvliet, N.I., 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine dendritic cells and their expression of accessory molecules, Toxicol. Appl. Pharmacol., 171, 117, 2001.
86. Vorderstrasse, B., Dearstyne, E. A., and Kerkvliet, N. I., Influence of 2,3,7,8-tetrachlorodibenzo- p-dioxin on the antigen-presenting activity of dendritic cells, Toxicol. Sci., 72, 103, 2003.
87. Ruby, C., Funatake, C., and Kerkvliet, N. I., 2,3,7,8-Tetrachlorodibenzo-p-dioxin directly enhances maturation and apoptosis of dendritic cells in vitro, J. Immunotoxicol., 1, 159, 2004.
88. Vecchi, A., et al., Effect of acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral antibody production in mice, Arch. Toxicol. Suppl. 4, 163, 1980.
89. Hinsdill, R., Couch, D., and Speirs, R., Immunosuppression in mice induced by dioxin (TCDD) in feed, J. Environ. Pathol. Toxicol., 4, 401, 1980.
90. Nohara, K., et al., Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxn on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57Bl/6 mice, Toxicology, 172, 49, 2002.
91. Lawrence, B.P. and Vorderstrasse, B., A kinetic study of the recall response to influenza virus infection in mice exposed to the immunosuppressive pollutant dioxin, Toxicol. Sci., 79, 304, 2004.
92. Kerkvliet, N.I. and Steppan, L., Suppression of allograft immunity by 3,4,5,3',4',5'-hexachlorobiphenyl. I. effects of exposure of tumor rejection and cytotoxic T cell activity in vivo, Immunopharmacology, 16, 1, 1988.
93. House, R., Lauer, L., and Murray, M., Examination of immune parameters and host resistance mechanisms in B6C3F1 mice following adult exposure to 2,3,7,8-tetrachlorodibenzo- p-dioxin, J. Toxicol. Environ. Health, 31, 203, 1990.
94. Yang, Y., Lebrec, H., and Burleson, G., Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on pulmonary influenza virus titer and natural killer (NK) activity in rats, Fundam. Appl. Toxicol., 23, 125, 1994.
95. Funseth, E. and Ilback, N., Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on blood and spleen natural killer (NK) cell activity in the mouse, Toxicol. Lett., 60, 247, 1992.
96. Ackerman, M., et al., Selective inhibition of polymorphonuclear neutrophil activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicol. Appl. Pharmacol., 101, 470, 1989.
97. Choi, J., Oughton, J., and Kerkvliet, N. I., Functional alterations in CD11b+Gr-1+ cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzop- dioxin, Int. Immunopharmacol., 3, 553, 2003.
98. Kerkvliet, N. and Oughton, J., Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlordibenzo-p-dioxin: Phenotypic and functional analysis of peritoneal exudate cells, Toxicol. Appl. Pharmacol., 119, 248, 1993.
99. Moos, A., Baecher-Steppan, L., and Kerkvliet, N., Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: The role of proinflammatory cytokines, IL-1 and TNF, Toxicol. Appl. Pharmacol., 127, 331, 1994.
100. Teske, S., et al., Exploring mechanisms that underlie aryl hydrocarbon receptor-mediated increases in pulmonary neutrophilia and diminished host resistance to influenza A virus, AJP-Lung Cell. Mol. Physiol., 289, 111, 2005.
101. Montavani, A., et al., Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell-mediated cytotoxicity in mice, Biomedicine, 32, 200, 1980.
102. Moos, A., Oughton, J., and Kerkvliet, N.I., The effects of 2,3,7,8-tetrachlorodibenzo-pdioxin on tumor necrosis factor (TNF) production by peritoneal cells, Toxicol. Lett., 90, 145, 1997.
103. Clark, G. and Taylor, M., Tumor necrosis factor involvement in the toxicity of TCDD: The role of endotoxin in the response, Exp. Clin. Immunogenet., 11, 136, 1994.
104. Lawrence, B.P. and Kerkvliet, N.I., Role of altered arachidonic acid metabolism in 2,3,7,8- tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice, Toxicol. Sci., 42, 13, 1998.
105. Vos, J. and Moore, J., Suppression of cellular immunity in rats and mice by maternal treatment with TCDD, Int. Arch. Allergy Appl. Immunol., 47, 777, 1974.
106. Luster, M., et al., Examination of bone marrow, immunologic parameters and host susceptibility following pre- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Int. J. Immunopharmacol., 2, 301, 1980.
107. Camacho, I., Nagarkatti, M., and Nagarkatti, P., Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzop- dioxin, Toxicol. Sci., 78, 96, 2004.
108. Gehrs, B., et al., Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: II. Effects on the pup and the adult, Toxicology, 122, 229, 1997.
109. Holladay, S., et al., Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to TCDD, Teratology 44, 385, 1991.
110. Nohara, K., et al., The effects of perinatal exposure to low doses of 2,3,7,8-tetrachlorodibenzo- p-dioxin on immune organs in rats, Toxicology, 154, 123, 2000.
111. Vorderstrasse, B., Cundiff, J., and Lawrence, B.P., Developmental exposure to the potent aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs the cellmediated immune response to infection with influenza A virus, but enhances elements of innate immunity, J. Immunotoxicol., 1, 103, 2004.
112. Fine, J., Gasiewicz, T., and Silverstone, A., Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Mol. Pharmacol., 35, 18, 1989.
113. Gehrs, B. and Smialowicz, R., Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicology, 134, 79, 1999.
114. Walker, D., et al., Persistent suppression of contact hypersensitivity and altered T cell parameters in F344 rats exposed perinatally to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Toxicology, 197, 57, 2004.
115. Vorderstrasse, B., Cundiff, J., and Lawrence, B.P., A dose-response study of the effects of prenatal and lactational exposure to TCDD on the immune response to influenza A virus, J. Toxicol. Environ. Health, 69, 445
116. Sugita-Konishi, Y., et al., Effect of lactaional exposure to 2,3,7,8-tetrachlorodibenzop- dioxin on the susceptibility ot Listeria infection, Biosci. Biotechnol. Biochem., 67, 89, 2003.
117. Kim, H., et al., Immunotoxicological effects of Agent Orange exposure to the Vietnam War Korean Veterans, Indust. Health, 41, 158, 2003.
118. Baccarelli, A., et al., Immunologic effects of dioixn: New results from Seveso and comparison with other studies, Environ. Health Perspect., 110, 1169, 2002.
119. Kimata, H., 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhances spontaneous IgE production in B cells from atopic patients, Int. J. Hyg. Environ. Health, 206, 601, 2003.
120. Ernst, M., et al., Immune cell functions in industrial workers after exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin: Dissociation of antigen-specific T cell responses in cultures of diluted whole blood and of isolated peripheral blood mononuclear cells, Environ. Health Perspect. 106 (Suppl. 2), 701, 1998.
121. Tonn, T., et al., Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-TCDD, Environ. Health Perspect., 104, 422, 1996.
122. Kerkvliet, N. and Brauner, J., Mechanisms of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD)-induced humoral immune suppression: Evidence of primary defect in T cell regulation, Tox. Appl. Pharmacol., 87, 18, 1987.
123. Neumann, C., Oughton, J., and Kerkvliet, N., Anti-CD3 induced T cell activation-II. effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Int. J. Immunopharmacol., 15, 543, 1993.
124. Dewailly, E., A et al., Susceptibility to infections and immune status in Inuit infants exposed to organochlorines, Environ. Health Perspect., 108, 205, 2000.
125. Weisglas-Kuperus, N., et al., Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants, Ped. Res., 38, 404, 1995.
126. Weisglas-Kuperus, N., Neurodevelopmental, immunological and endocrinological indices of perinatal human exposure to PCBs and dioxins, Chemosphere, 37, 1845, 1998.
127. Weisglas-Kuperus, N., et al., Immunologic effects of background exposure to polychlorinated biphenyls, Environ. Health Perspect., 108, 1203, 2000.
128. Nagayama, J., et al., Postnatal exposure to chlorinated dioxins and related chemicals on lymphocyte subsets in Japanese breast fed infants, Chemosphere, 37, 1781, 1998.
129. ten Tusscher, T., et al., Decreased lung function associated with perinatal exposure to Dutch background levels of dioxins, Acta Pediat., 90, 1292, 2001.
130. Vanden Heuvel, R. L., et al., Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents, Environ. Health Perspect., 110, 595, 2002.
131. ten Tusscher, G., et al., Persistent hematologic and immunologic disturbances in 8-year old Dutch children associated with perinatal dioxin exposure, Environ. Health Perspect., 111, 1519, 2003.